InvestorsHub Logo
Followers 30
Posts 8840
Boards Moderated 0
Alias Born 12/15/2004

Re: Sanoman post# 26607

Friday, 12/30/2005 3:23:54 PM

Friday, December 30, 2005 3:23:54 PM

Post# of 64738
Sanoman: I know that AVII was working on utilizing antisense morpholinos to combat transplant rejection. But they have moved their anti-viral platform to the forefront and everything else has fallen to the wayside.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.